MindWalk Holdings (HYFT) Acquisitions (2023 - 2026)
MindWalk Holdings (HYFT) posted quarterly Acquisitions of -$1.8 million for Q1 2026, down 126.56% year-over-year from $6.6 million in Q1 2025, and down 120.97% quarter-over-quarter from $8.4 million in Q4 2025.
MindWalk Holdings (HYFT) Acquisitions (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Acquisitions for 4 consecutive years, with -$1.8 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -1.76 Mn |
| Oct 31, 2025 | 8.37 Mn |
| Jul 31, 2025 | 3.56 Mn |
| Jan 31, 2025 | 6.61 Mn |
| Oct 31, 2024 | -277,537.42 |
| Jul 31, 2024 | 2.86 Mn |
| Jan 31, 2024 | 138,327.92 |
| Oct 31, 2023 | -525,095.65 |
| Jul 31, 2023 | 5.04 Mn |
| Jan 31, 2023 | -2.77 Mn |